Combinatorial control of the specificity of protein tyrosine phosphatases

Current Opinion in Cell Biology

Volumn 13, Issue 2, 2001, Pages 182-195

  Tonks, Nicholas K ^a   Neel, Benjamin G ^b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; PHOSPHOPROTEIN PTP1B; PHOSPHOPROTEIN TCPTP; PROTEIN KINASE P60; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

DEPHOSPHORYLATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME SPECIFICITY; GENE TARGETING; HOUSEKEEPING GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035313868     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00196-4     Document Type: Review

References (129)

1. 'Zip codes' direct intracellular protein tyrosine phosphatases to the correct cellular 'address'
2. Protein tyrosine phosphatases in signal transduction
3. Protein tyrosine phosphatases: Mechanisms of catalysis and regulation
4. Crystal structure of human protein tyrosine phosphatase 1B
5. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate
6. Protein tyrosine phosphatases take off
7. Crystal structure of the dual specificity protein phosphatase VHR
8. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A
9. Protein phosphatases and the regulation of mitogen activated protein kinase signaling
10. Dual specificity phosphatases: A gene family for control of MAP kinase function
11. Extracellular signals and scores of phosphatases: All roads lead to MAP kinase
12. Cdc25 protein phosphatases in cell proliferation
13. Dephosphorylation of Cdk2 Thr 160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin
14. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR
15. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro
16. Elucidating the essential role of the A14 phosphoprotein in vaccinia morphogenesis: Construction and characterization of a tetinducible recombinant
17. Tyrosine phosphorylation of A17 during vaccinia virus infection: Involvement of the H1 phosphatase and the F10 kinase
18. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
19. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
20. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate
21. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
22. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
23. A gene mutated in X-linked myotubular myophathy defines a new putative tyrosine phosphatase family conserved in yeast
24. Inaugural article: Myotubularin, a protein-tyrosine phosphatase mutated in myotubulary myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate
25. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase annd phosphatidylinositol 3-phosphate pathway
26. Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography
27. Identification of p130cas as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST
28. Development of 'substrate trapping' mutants to identify physiological substrates of protein-tyrosine phosphatases
29. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model
30. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts
31. Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition
32. Cytoskeletal protein PSTPIP1 directs PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation
33. Regulation of fibroblast motility by the protein tyrosine phosphtase PTP-PEST
34. cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family
35. Cloning of a cDNA for a major human protein-tyrosine-phosphatase
36. Cloning and expression of a protein-tyrosine-phosphatase
37. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B
38. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence
39. Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts
40. Phosphorylation of protein-tyrosine phosphatase PTP-1B on identical sites suggests activation of a common signaling pathway during mitosis and stress reponse in mammalian cells
41. Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: Identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation
42. Protein tyrosine phosphatase 1B undergoes mitosis-specific phosphorylation on serine
43. Cas
44. The T-cell protein tyrosine phosphatase
45. Protein-tyrosine-phosphatase 1B is a negative regulator of insulin- and insulin-like growth-factor-I-stimulated signaling
46. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase
47. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase signaling
48. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice
49. Increased insulin sensitivity and obesity resistance in mice lacking the protein-tyrosine phosphatase-1B gene
50. Increased energy expenditure, decreased adiposity and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
51. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B
52. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
53. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B
54. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR
55. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells
56. NMR analysis of regioselectivity in dephosphorylation of a triphosphoryl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase
57. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinnase by preferential dephosphorylation of the receptor regulatory domain
58. Over-expression of the protein-tyrosine phosphatase leukocyte antigen related (LAR) in muscle causes insulin resistance
59. Genetic analysis of protein tyrosine phosphatases
60. Role of phosphatases in lymphocyte activation
61. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases
62. Shp-2 tyrosine phosphatase: Signaling one cell or many
63. Revealing mechanisms for SH2 domain-mediated regulation of the protein tyrosine phosphatase SHP-2
64. Inhibitory receptors abound?
65. SH-PTP2 SH2 domain binding specificity is defined by direct interactions with PDGF receptor, EGF receptor, and IRS-1 derived phosphopeptides
66. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
67. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library
68. Molecular basis of the motheaten phenotype
69. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine phosphatase deficiency
70. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: Regulators of B cell signal transduction
71. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
72. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of binding sites
73. Immune inhibitory receptors
74. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells
75. Insulin signaling in mice expressing reduced levels of Syp
76. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase SHP-2
77. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases
78. Protein-tyrosine phosphatase SHP-2 regulates cell spreading, migration and focal adhesion
79. Regulation of early events in integrin signaling by the protein-tryosine phosphatase SHP-2
80. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development
81. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals
82. Mice mutant for Egfr and Shp2 have defective cardiac semilunnar valvulogenesis
83. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development
84. Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera
85. Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction
86. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps
87. Crystal structure of the SH2 domain phosphatase SHP-2
88. Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1
89. Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1
90. Regulation of CSF-1 receptor signaling in murine macrophages by the SH2-containing tyrosine phosphatase SHPTP1
91. Mitogen-activated protein kinase pathways
92. Organization and regulation of mitogen-activated protein kinase signaling cascades
93. The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine phosphatase
94. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo
95. Catalytic activation of the phosphtase MKP-3 by Erk2 mitogen-activated protein kinase
96. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases Erk1 and Erk2 by association through a kinase interaction motif
97. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP)
98. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase
99. The MAP-kinase Erk2 is a specific substrate of the protein tyrosine phosphatase HePTP
100. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase
101. Ig superfamily phosphatases
102. The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal recognition molecule contaction
103. Pleiotrophin signals increase tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta
104. Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization
105. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha
106. Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface
107. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge
108. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity
109. The crystal structure of domain 1 of receptor protein-tyrosine phosphatase mu
110. Crystal structure of the tandem phosphatase domains of RPTP LAR
111. Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins
112. Tyrosine phosphatase activity of lymphoma CCD45 (GP180) is regulated by a direct interaction with the cytoskeleton
113. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains
114. The Trio guanine nucleotide exchange factor is a Rho A target. Binding of RhoA to the trio immunoglobulin-like domain
115. The CD45 tyrosine phosphatase: A positive and negative regulator of immune cell function
116. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase
117. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts
118. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn
119. Structures of Src-family tyrosine kinases
120. Receptor tyrosine phosphatase R-PTP-alpha is tyrosine-phosphorylated and associated with the adaptor protein Grb2
121. Phosphorylation of receptor protein-tyrosine phosphatase a on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo
122. A phosphotyrosine displacement mechanism for activation of Src by PTPα
123. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity
124. Deficient LAR expression decreases basal forbrain cholinergic size and hippocampal cholinergic innervation
125. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
126. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice
127. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma
128. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma
129. Protein tyrosine phosphatases in the developing nervous system